Koji Eto

12.6k total citations · 3 hit papers
157 papers, 8.9k citations indexed

About

Koji Eto is a scholar working on Hematology, Molecular Biology and Surgery. According to data from OpenAlex, Koji Eto has authored 157 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Hematology, 60 papers in Molecular Biology and 28 papers in Surgery. Recurrent topics in Koji Eto's work include Platelet Disorders and Treatments (64 papers), Pluripotent Stem Cells Research (29 papers) and Cell Adhesion Molecules Research (21 papers). Koji Eto is often cited by papers focused on Platelet Disorders and Treatments (64 papers), Pluripotent Stem Cells Research (29 papers) and Cell Adhesion Molecules Research (21 papers). Koji Eto collaborates with scholars based in Japan, United States and India. Koji Eto's co-authors include Satoshi Nishimura, Sanford J. Shattil, Hiromitsu Nakauchi, Makoto Otsu, Naoya Takayama, Ryozo Nagai, Takashi Kadowaki, Masao Nagasaki, Ichiro Manabe and Kotaro Yoshimura and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Koji Eto

149 papers receiving 8.8k citations

Hit Papers

CD8+ effector T cells contribute to macrophage recruitmen... 2003 2026 2010 2018 2009 2003 2012 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Koji Eto Japan 42 3.4k 2.5k 2.0k 1.6k 1.5k 157 8.9k
Désiré Collen Belgium 56 4.1k 1.2× 2.5k 1.0× 880 0.4× 665 0.4× 1.1k 0.8× 133 10.2k
Anton Jan van Zonneveld Netherlands 57 5.0k 1.5× 1.9k 0.8× 1.1k 0.6× 517 0.3× 737 0.5× 211 10.6k
Joseph E. Italiano United States 50 2.9k 0.9× 5.1k 2.0× 1.6k 0.8× 719 0.5× 471 0.3× 133 9.7k
Mark L. Kahn United States 55 2.5k 0.7× 5.1k 2.0× 1.4k 0.7× 1.0k 0.6× 787 0.5× 132 10.3k
Daniel F. Bowen‐Pope United States 54 6.9k 2.1× 1.2k 0.5× 2.0k 1.0× 1.5k 0.9× 1.0k 0.7× 105 13.1k
M A Reidy United States 60 5.6k 1.7× 1.6k 0.6× 2.0k 1.0× 2.1k 1.3× 1.1k 0.8× 120 13.4k
H.R. Lijnen Belgium 52 2.5k 0.8× 3.2k 1.3× 661 0.3× 647 0.4× 785 0.5× 192 9.2k
Volkhard Lindner United States 50 4.7k 1.4× 738 0.3× 1.3k 0.7× 1.4k 0.9× 670 0.5× 90 9.1k
Denisa D. Wagner United States 53 1.9k 0.6× 5.6k 2.2× 2.2k 1.1× 1.8k 1.1× 353 0.2× 80 9.5k
Joanne E. Murphy-Ullrich United States 56 5.8k 1.7× 522 0.2× 2.2k 1.1× 1.5k 0.9× 938 0.6× 111 11.3k

Countries citing papers authored by Koji Eto

Since Specialization
Citations

This map shows the geographic impact of Koji Eto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koji Eto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koji Eto more than expected).

Fields of papers citing papers by Koji Eto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koji Eto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koji Eto. The network helps show where Koji Eto may publish in the future.

Co-authorship network of co-authors of Koji Eto

This figure shows the co-authorship network connecting the top 25 collaborators of Koji Eto. A scholar is included among the top collaborators of Koji Eto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koji Eto. Koji Eto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takayama, Naoya, Motohiko Oshima, Bahityar Rahmutulla, et al.. (2024). iPSC-derived megakaryocytes and platelets accelerate wound healing and angiogenesis. Stem Cell Research & Therapy. 15(1). 364–364. 3 indexed citations
2.
Sugimoto, Naoshi, Sou Nakamura, Shin Shimizu, et al.. (2022). Production and nonclinical evaluation of an autologous iPSC–derived platelet product for the iPLAT1 clinical trial. Blood Advances. 6(23). 6056–6069. 23 indexed citations
3.
Kumon, H, Shinya Sakuma, Sou Nakamura, et al.. (2021). Microfluidic Bioreactor Made of Cyclo-Olefin Polymer for Observing On-Chip Platelet Production. Micromachines. 12(10). 1253–1253. 6 indexed citations
4.
Eto, Koji. (2019). Platelets using iPS cell technology; large scale manufacturing. PubMed. 15(2). 52–52. 1 indexed citations
5.
Tadokoro, Yuko, Takayuki Hoshii, Satoshi Yamazaki, et al.. (2018). Spred1 Safeguards Hematopoietic Homeostasis against Diet-Induced Systemic Stress. Cell stem cell. 22(5). 713–725.e8. 27 indexed citations
6.
Sugimoto, Naoshi & Koji Eto. (2017). Development of iPS cell-derived blood products and production guidelines.. PubMed. 58(10). 2150–2159. 1 indexed citations
7.
Nakamura, Sou, Tomohiro Shigemori, Naoshi Sugimoto, et al.. (2016). High-Vorticity with Periodic Flow Enhances in Vitro Biogenesis of Healthy Platelets from iPSC-Derived-Megakaryocytes. Blood. 128(22). 2181–2181. 1 indexed citations
8.
Ishihara, Jun, Terumasa Umemoto, Masayuki Yamato, et al.. (2014). Nov/CCN3 regulates long-term repopulating activity of murine hematopoietic stem cells via integrin αvβ3. International Journal of Hematology. 99(4). 393–406. 25 indexed citations
9.
Kim‐Kaneyama, Joo‐ri, Xiao‐Feng Lei, Susila Arita, et al.. (2012). Identification of Hic‐5 as a novel regulatory factor for integrin αIIbβ3 activation and platelet aggregation in mice. Journal of Thrombosis and Haemostasis. 10(9). 1867–1874. 9 indexed citations
10.
Takayama, Naoya, Koji Eto, & Hiromitsu Nakauchi. (2011). [Potential usefulness of human iPS cells on the generation of platelets].. PubMed. 69(12). 2161–5. 1 indexed citations
11.
Yamazaki, Satoshi, Atsushi Iwama, Shin‐ichiro Takayanagi, et al.. (2008). TGF-β as a candidate bone marrow niche signal to induce hematopoietic stem cell hibernation. Blood. 113(6). 1250–1256. 229 indexed citations
12.
Nishikii, Hidekazu, Koji Eto, Noriko Tamura, et al.. (2008). Metalloproteinase regulation improves in vitro generation of efficacious platelets from mouse embryonic stem cells. The Journal of Experimental Medicine. 205(8). 1917–1927. 44 indexed citations
13.
Oki, Toshihiko, Jiro Kitaura, Koji Eto, et al.. (2006). Integrin αIIbβ3 Induces the Adhesion and Activation of Mast Cells through Interaction with Fibrinogen. The Journal of Immunology. 176(1). 52–60. 35 indexed citations
14.
Kitaura, Jiro, Koji Eto, Tatsuya Kinoshita, et al.. (2005). Regulation of Highly Cytokinergic IgE-Induced Mast Cell Adhesion by Src, Syk, Tec, and Protein Kinase C Family Kinases. The Journal of Immunology. 174(8). 4495–4504. 58 indexed citations
15.
Tadokoro, Seiji, Sanford J. Shattil, Koji Eto, et al.. (2003). Talin Binding to Integrin ß Tails: A Final Common Step in Integrin Activation. Science. 302(5642). 103–106. 981 indexed citations breakdown →
16.
Eto, Koji. (2001). Two distinct mechanisms are involved in stent thrombosis under flow conditions. Platelets. 12(4). 228–235. 14 indexed citations
17.
Uehara, Masato, Koji Eto, Hideaki Maeda, & Junichi Hojo. (2000). Change of Morphology during Heating of Amorphous Composite Powder in Si3N4-BN System (特集 アモルファス・ナノ結晶制御と高機能材料). 47(4). 396–399. 1 indexed citations
19.
Ochiai, Masahiko, Takaaki Isshiki, Satoshi Takeshita, et al.. (1997). Use of Cilostazol, a Novel Antiplatelet Agent, in a Post-Palmaz-Schatz Stenting Regimen. The American Journal of Cardiology. 79(11). 1471–1474. 33 indexed citations
20.
Nakamura, Masahiko, et al.. (1996). Antiarrhythmic Effects of Optical Isomers of Disopyramide on Canine Ventricular Arrhythmias. Journal of Cardiovascular Pharmacology. 27(3). 368–375. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026